Stem
cells are a vital component of regenerative medicine therapies,
however, only a fraction of stem cells delivered to the central nervous
system following injury survive the inflammatory environment. Previously,
we showed that subcutaneous preconditioning of neural stem cell (NSC)
embedded hydrogels for 28 days improved spinal cord injury (SCI) functional
outcomes over controls. Here, we investigated the mechanism of subcutaneous
preconditioning of NSC-embedded hydrogels, with and without the known
neurogenic cue, interferon gamma (IFN-γ), for 3, 14, or 28 days
to refine and identify subcutaneous preconditioning conditions by
measurement of neurogenic markers and cytokines. Studying the preconditioning
mechanism, we found that subcutaneous foreign body response (FBR)
associated cytokines infiltrated the scaffold in groups with and without
NSCs, with time point effects. A pro-inflammatory environment with
upregulated interleukin (IL)-6, IL-10, macrophage inflammatory protein
(MIP)-1, MIP-2, IFN-γ-inducible protein 10 (IP-10), tumor necrosis
factor-α (TNF-α), and IL-12p70 was observed on day 3.
By 14 and 28 days, there was an increase in pro-regenerative cytokines
(IL-13, IL-4) along with pro-inflammatory markers IL-1β, IP-10,
and RANTES (regulated on activation, normal T cell expressed, and
secreted) potentially part of the mechanism that had an increased
functional outcome in SCI. Coinciding with changes in cytokines, the
macrophage population increased over time from 3 to 28 days, whereas
neutrophils peaked at 3 days with a significant decrease at later
time points. Expression of the neuronal marker βIII tubulin
in differentiating NSCs was supported at 3 days in the presence of
soluble and immobilized IFN-γ and at 14 days by immobilized
IFN-γ only, but it was greatly attenuated in all conditions
at 28 days, partially because of dilution via host cell infiltration.
We conclude that subcutaneously incubating NSC seeded scaffolds for
3 or 14 days could act as host specific preconditioning through exposure
to FBR while retaining βIII tubulin expression of NSCs to further
improve the SCI functional outcome observed with 28 day subcutaneous
incubation.